[Combination therapy for osteoporosis].
Hagino
Hiroshi
H
Rehabilitation Division, Tottori University Hospital.
D019386:Alendronate / Q000008:administration & dosage; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D002116:Calcitonin / Q000008:administration & dosage; D002118:Calcium / Q000008:administration & dosage; D002762:Cholecalciferol / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage; D024482:Vitamin K 2 / Q000008:administration & dosage
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D024482:Vitamin K 2; D002762:Cholecalciferol; D020849:Raloxifene Hydrochloride; D002116:Calcitonin; D002118:Calcium; D019386:Alendronate